Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
3(18%)
Results Posted
38%(3 trials)
Terminated
2(12%)

Phase Distribution

Ph phase_3
1
6%
Ph phase_2
7
41%
Ph not_applicable
6
35%
Ph phase_1
1
6%
Ph phase_4
2
12%

Phase Distribution

1

Early Stage

7

Mid Stage

3

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
1(5.9%)
Phase 2Efficacy & side effects
7(41.2%)
Phase 3Large-scale testing
1(5.9%)
Phase 4Post-market surveillance
2(11.8%)
N/ANon-phased studies
6(35.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

61.5%

8 of 13 finished

Non-Completion Rate

38.5%

5 ended early

Currently Active

3

trials recruiting

Total Trials

17

all time

Status Distribution
Active(3)
Completed(8)
Terminated(5)
Other(1)

Detailed Status

Completed8
Withdrawn3
Recruiting2
Terminated2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
3
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.9%)
Phase 27 (41.2%)
Phase 31 (5.9%)
Phase 42 (11.8%)
N/A6 (35.3%)

Trials by Status

recruiting212%
terminated212%
active_not_recruiting16%
completed847%
withdrawn318%
unknown16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT07238400Phase 2

Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia

Recruiting
NCT03253172Not Applicable

Potassium Supplementation in CKD

Active Not Recruiting
NCT04316611Phase 2

Potassium Chloride in Out-of-hospital Cardiac Arrest Due to Refractory Ventricular Fibrillation

Withdrawn
NCT04913805Phase 2

Matching Perfusion and Metabolic Activity in HFpEF

Recruiting
NCT05758142Not Applicable

Potassium Intake-response Trial to Control Hypertension

Terminated
NCT02450773Phase 2

Prevention of Severe Postpartum Hypertension

Withdrawn
NCT03627130Phase 2

The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy

Completed
NCT04755400Not Applicable

The Effect of Orally Administrated Nitrate on Renal Parameters and Systemic Haemodynamics

Completed
NCT03483051Phase 2

Targeting Pulsatile Load to Increase Exercise Capacity and Quality of Life After Aortic Valve Replacement for Severe Aortic Stenosis (PULSE AS)

Completed
NCT00357214Not Applicable

Effect of Potassium Bicarbonate Supplementation on Bone and Muscle in Older Adults

Completed
NCT01074918Phase 1

Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients

Withdrawn
NCT01818583Phase 4

Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter

Completed
NCT02982356Not Applicable

Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy

Unknown
NCT00241839Phase 3

Uric Acid and Hypertension in African Americans

Completed
NCT01085071Phase 4

Comparison of Two Potassium Targets Within the Normal Range in Intensive Care Patients

Completed
NCT00913796Phase 2

Metabolic Acidosis in Renal Transplant Patients

Completed
NCT00224939Not Applicable

Pre-ESRD Syndrome in High Risk African Americans

Terminated

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17